secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001104659-23-047912
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics amends bylaws to enhance stockholder proposal and nomination procedures
--------------------------------------------------------------------------------

- Amendments require additional background info on proposing stockholders and nominees, and representation on solicitation intentions.
- Updates procedural mechanics for adjourned meetings, inspectors of election, and proxy revocability.
- Eliminates stockholder list inspection at meetings; opts out of DGCL Section 116 for written delivery of notices.
- Certificates and uncertificated shares must conspicuously state company is a public benefit corporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465923047912/0001104659-23-047912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465923047912/tm2313121d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-047912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer